HomeIndustriesCryptoHow AlphaTON (ATON) is Funding Cancer Research Through Tokenization

How AlphaTON (ATON) is Funding Cancer Research Through Tokenization

Anthony Scaramucci and Brittany Kaiser explain how AlphaTON are using digital assets to fund cancer research and launch companies within blockchain and the “Telegram ecosystem.” AlphaTON (ATON) owns multiple molecules and is looking for “innovative ways” to combine their biotech knowledge with financial systems expertise. Brittany notes that it is hard to raise money for biotech right now, but it’s easy to fundraise for digital assets.

Trading 360

14 Oct 2025

SHARE

ON AIR
9:00 am
Morning Trade Live
12:00 am
The Wrap
REPLAY
12:30 am
Market On Close
REPLAY
education
2:00 am
Your First Trade
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY
5:00 am
Market Overtime
REPLAY
5:30 am
The Wrap
REPLAY
7:00 am
Morning Movers
8:00 am
Opening Bell With Nicole Petallides
ON AIR
9:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
4:00 pm
Fast Market
REPLAY
5:00 pm
Next Gen Investing
REPLAY
6:00 pm
The Wrap
REPLAY
education
7:30 pm
Schwab 2026 Outlook
REPLAY
8:30 pm
Market On Close
REPLAY
education
10:00 pm
Schwab 2026 Outlook
REPLAY
11:00 pm
The Wrap
REPLAY

Schwab Network's Newsletters

Daily insights for every investor